Bayesian Networks for Risk Prediction Using Real-World Data: A Tool for Precision Medicine

被引:88
|
作者
Arora, Paul [1 ,2 ]
Boyne, Devon [2 ,3 ]
Slater, Justin J. [2 ]
Gupta, Alind [2 ,4 ]
Brenner, Darren R. [5 ]
Druzdzel, Marek J. [6 ]
机构
[1] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, 155 Coll St 6th Floor, Toronto, ON M5T 1P8, Canada
[2] Lighthouse Outcomes, Toronto, ON, Canada
[3] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada
[4] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
[5] Univ Calgary, Dept Oncol & Community Hlth Sci, Cumming Sch Med, Calgary, AB, Canada
[6] Univ Pittsburgh, Sch Comp & Informat, Pittsburgh, PA USA
关键词
artificial intelligence; Bayesian networks; decision models; machine learning; precision medicine; real-world data; regression-based models; risk prediction; statistical methods; CHRONIC KIDNEY-DISEASE; MODEL;
D O I
10.1016/j.jval.2019.01.006
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective: The fields of medicine and public health are undergoing a data revolution. An increasing availability of data has brought about a growing interest in machine-learning algorithms. Our objective is to present the reader with an introduction to a knowledge representation and machine-learning tool for risk estimation in medical science known as Bayesian networks (BNs). Study Design: In this article we review how BNs are compact and intuitive graphical representations of joint probability distributions (JPDs) that can be used to conduct causal reasoning and risk estimation analysis and offer several advantages over regression-based methods. We discuss how BNs represent a different approach to risk estimation in that they are graphical representations of JPDs that take the form of a network representing model random variables and the influences between them, respectively. Methods: We explore some of the challenges associated with traditional risk prediction methods and then describe BNs, their construction, application, and advantages in risk prediction based on examples in cancer and heart disease. Results: Risk modeling with BNs has advantages over regression-based approaches, and in this article we focus on three that are relevant to health outcomes research: (1) the generation of network structures in which relationships between variables can be easily communicated; (2) their ability to apply Bayes's theorem to conduct individual-level risk estimation; and (3) their easy transformation into decision models. Conclusions: Bayesian networks represent a powerful and flexible tool for the analysis of health economics and outcomes research data in the era of precision medicine.
引用
下载
收藏
页码:439 / 445
页数:7
相关论文
共 50 条
  • [21] Real-World Data Generalization for Glaucoma Prediction
    Rashidisabet, Homa
    Chan, R. V. Paul
    Vajaranant, Thasarat S.
    Yi, Darvin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [22] Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine
    Lee, Hyunwoo
    Cho, Yoon Ah
    Kim, Deok Geun
    Cho, Eun Yoon
    CANCER RESEARCH AND TREATMENT, 2024, 56 (01): : 149 - 161
  • [23] Development of a prediction model for hypereosinophilic syndrome using real-world data
    Carstens, Donna
    Ogbogu, Princess
    Chung, Yen
    Cheng, Mu
    Cook, Erin
    Mu, Fan
    Judson, Elizabeth
    Chen, Jingyi
    Wang, Travis
    Chen, Zhuo
    Khoury, Paneez
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB216 - AB216
  • [24] Hybrid Traffic Speed Modeling and Prediction Using Real-world Data
    Zhang, Rong
    Shu, Yuanchao
    Yang, Zequ
    Cheng, Peng
    Chen, Jiming
    2015 IEEE INTERNATIONAL CONGRESS ON BIG DATA - BIGDATA CONGRESS 2015, 2015, : 230 - 237
  • [25] Estimating Systematic Risk in Real-World Networks
    Laszka, Aron
    Johnson, Benjamin
    Grossklags, Jens
    Felegyhazi, Mark
    FINANCIAL CRYPTOGRAPHY AND DATA SECURITY, FC 2014, 2014, 8437 : 417 - 435
  • [26] Fall Risk Prediction in Parkinson's Disease Using Real-World Inertial Sensor Gait Data
    Ullrich, Martin
    Roth, Nils
    Kuederle, Arne
    Richer, Robert
    Gladow, Till
    Gassner, Heiko
    Marxreiter, Franz
    Klucken, Jochen
    Eskofier, Bjoern. M. M.
    Kluge, Felix
    IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2023, 27 (01) : 319 - 328
  • [27] Real-World Battles with Real-World Data
    Brown, Jeffrey
    Bate, Andrew
    Platt, Robert
    Raebel, Marsha
    Sauer, Brian
    Trifiro, Gianluca
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 254 - 255
  • [28] Real-World Data as an Evidence Source in Nuclear Medicine
    Bourla, Ariel B.
    Herrmann, Ken
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (02) : 156 - 157
  • [29] Small But Mighty: The Use of Real-World Evidence to Inform Precision Medicine
    Miksad, Rebecca A.
    Samant, Meghna K.
    Sarkar, Somnath
    Abernethy, Amy P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 87 - 90
  • [30] Deploying the MS Bioscreen in the clinic: towards real-world precision medicine
    Bove, R.
    Lizee, A.
    Garcha, P.
    Hauser, S. L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 674 - 674